Elie S. Nuwayser

Depot naltrexone: long-lasting antagonism of the effects of heroin in humans

Sandra D. Comer, Eric D. Collins, Herbert D. Kleber et al. · Psychopharmacology · 2002 · 175 citations · Full text

Opioid Epidemic, Molecular Pharmacology, Substance Abuse +15

Sustained‐Release Naltrexone for Alcoholism Treatment: A Preliminary Study

Henry R. Kranzler, Vania Modesto‐Lowe, Elie S. Nuwayser · Alcoholism Clinical and Experimental Research · 1998 · 119 citations

Substance Abuse, Substance Use, Ntx 50 +14

Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification

Bai-Fang X Sobel, Stacey C. Sigmon, Sharon Walsh et al. · Drug and Alcohol Dependence · 2003 · 57 citations

Opioid Epidemic, Open-label Trial, Substance Abuse +12

A Multisite Pilot Study of Extended-Release Injectable Naltrexone Treatment for Previously Opioid-Dependent Parolees and Probationers

Donna M. Coviello, James Cornish, Kevin G. Lynch et al. · Substance Abuse · 2012 · 57 citations · Full text

Opioid Epidemic, Substance Use, Pharmacotherapy +18

An injection depot formulation of buprenorphine: extended biodelivery and effects

Stacey C. Sigmon, David E. Moody, Elie S. Nuwayser et al. · Addiction · 2006 · 53 citations